Publications by authors named "D F Uria"
Article Synopsis
- Early identification of the transition from relapsing-remitting multiple sclerosis (RRMS) to secondary progressive MS (SPMS) is complex, mainly relying on assessing physical disability.
- A panel of 15 medical experts reached consensus on 72 out of 83 items regarding patient monitoring and the best clinical and paraclinical variables to detect early disease progression in MS, utilizing the RAND/UCLA Appropriateness Method.
- The established consensus can help neurologists better identify early SPMS progression, enabling them to plan more effective clinical and therapeutic interventions right from the beginning stages.
Aim: To evaluate the effectiveness and safety of fingolimod in routine clinical practice in the region of Asturias and Cantabria (Spain).
Patients And Methods: We conducted a retrospective multicentre study of patients with relapsing-remitting multiple sclerosis treated with fingolimod, in accordance with the product data sheet. Effectiveness was evaluated in patients with at least one year's treatment.
Multiple reaction monitoring (MRM) ratios as provided by tandem mass spectrometers are used to confirm positive residue findings (e.g. veterinary drugs or pesticides).
View Article and Find Full Text PDF